Douglas Lane & Associates, LLC Zoetis Inc. Transaction History
Douglas Lane & Associates, LLC
- $6.59 Billion
- Q1 2025
A detailed history of Douglas Lane & Associates, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 172,552 shares of ZTS stock, worth $27.3 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
172,552
Previous 97,395
77.17%
Holding current value
$27.3 Million
Previous $15.9 Million
79.04%
% of portfolio
0.43%
Previous 0.23%
Shares
32 transactions
Others Institutions Holding ZTS
# of Institutions
2,093Shares Held
417MCall Options Held
1.24MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA41.6MShares$6.57 Billion0.13% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$5.82 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.8MShares$3.14 Billion0.13% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16MShares$2.53 Billion2.4% of portfolio
-
Morgan Stanley New York, NY11.8MShares$1.87 Billion0.14% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $74B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...